Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03527225 Completed - Cancer Clinical Trials

Music of Choice to Decrease Anxiety During Radiation Treatment

Start date: January 22, 2018
Phase: N/A
Study type: Interventional

The primary hypothesis of the study is that listening to music will reduce anxiety in female cancer patients during the first radiotherapy treatment session.

NCT ID: NCT03525236 Completed - Cancer Clinical Trials

The Oncoflavour Study

Start date: June 19, 2017
Phase: N/A
Study type: Interventional

Oral nutritional supplements (ONS) are often prescribed for malnourished patients to help improve nutritional status. Commonly in cancer patients taste and smell alterations and side effects of treatment can affect the palatability and compliance to ONS. A variety of flavours and styles are available of ONS however research of the palatability of these in cancer patients is limited. This study aims to evaluate specific flavours created based on the taste changes occuring during treatment. We aim to evaluate the patient liking and evaluation of 5 flavors in 3 different types of flavour-sensations: - Warming/spicy sensation: to trigger the senses and bring new sensations - Cooling/fresh sensation: to have a fresh mouthfeel and lighter base perception - Neutral: to avoid that patients experience additional flavour and let them the opportunity to mix it with other food

NCT ID: NCT03522467 Recruiting - Cancer Clinical Trials

Cannabis Oil for Pain Effectiveness

COPE
Start date: July 25, 2018
Phase: Phase 2
Study type: Interventional

This project represents a first systematic, prospective, single-arm cohort study of a safe and effective dosing regimen of an orally administered cannabis oil formulation in a cancer subject population with poorly controlled pain.

NCT ID: NCT03520959 Terminated - Cancer Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Start date: September 18, 2018
Phase: Phase 3
Study type: Interventional

To assess if the CMB305 vaccine regimen may help the body's immune system to slow or stop the growth of synovial sarcoma tumor and improve survival.

NCT ID: NCT03519074 Recruiting - Cancer Clinical Trials

Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction

Start date: July 22, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to formally characterize the pharmacokinetics (PK), safety, and tolerability of TS-1 in combination with cisplatin in adult patients with advanced solid tumors who have mild, moderate or severe hepatic impairment relative to patients with normal hepatic function, as categorized by the United States National Cancer Institute organ dysfunction working group [NCI-ODWG] criteria for hepatic dysfunction.

NCT ID: NCT03518255 Completed - Cancer Clinical Trials

e-Natureza Project - Affective Validation of Nature Images for Hospital Use

E-natureza
Start date: August 22, 2018
Phase: N/A
Study type: Interventional

Randomized clinical trial about the evaluation of the use of nature photographs in the positive and negative affects of oncological patients.

NCT ID: NCT03515174 Active, not recruiting - Cancer Clinical Trials

Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO

Start date: April 16, 2018
Phase: N/A
Study type: Interventional

Adolescents and young adults (AYA) patients experience significant distress in specific areas at diagnosis. The investigators hypothesize that providing developmentally-appropriate AYA-specific psychosocial care, with an individualized multi-disciplinary program will alleviate this distress, as well as improve health-related quality of life (HRQOL). The investigators' primary aim is to evaluate the impact of psychosocial interventions on HRQOL. The secondary aims are to firstly identify the types of psychosocial distress experienced and secondly, to assess the feasibility of implementing a psychosocial screening and intervention program amongst AYA patients newly diagnosed with cancer.

NCT ID: NCT03514680 Completed - Cancer Clinical Trials

Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

Start date: June 4, 2018
Phase: N/A
Study type: Interventional

This research study is evaluating how well a decision support tool works to improve clinicians' use of recommended chemotherapy-induced peripheral neuropathy (CIPN) assessment and management strategies in participants receiving chemotherapy.

NCT ID: NCT03512899 Completed - Cancer Clinical Trials

Comparison Between Internal Jugular Vein Versus Axillary Vein for Implantable Ports

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Comparison between internal jugular vein versus via axillary vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 12 months.

NCT ID: NCT03509428 Recruiting - Cancer Clinical Trials

The Wessex Fit-4-Cancer Surgery Trial

WesFit
Start date: March 26, 2018
Phase: N/A
Study type: Interventional

Trial Phase: Phase III: A multi-centre efficacy pragmatic factorial design randomised controlled trial with patient informed development and process evaluation Indication: Patients undergoing major electively resectable intra - cavity cancer surgery with or without neoadjuvant cancer treatments (including chemotherapy (NAC), chemoradiotherapy (CRT), or immunotherapy). Objective: To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support on surgical outcome by reducing postoperative length of stay (LOS) and complications. Secondary Objective: To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support to improve disease-free overall survival. Cardiopulmonary Exercise test (CPET) variables, physical activity, morbidity, radiological markers of sarcopenia, toxicity, tumour down-staging, tumour regression, disability adjusted survival (WHODAS) overall survival and quality of life (QoL).